Pharmaceuticals Miss the Party
As the U.S. equity markets turn in a second month of gains, the pharmaceuticals sector has been left behind. After bottoming in early March, the market has turned in consecutive weeks of postive results with the SPDR S&P 500 ETF (SPY) up 29% from the low.